<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">324538</id>
  <title nil="true"/>
  <common-name>[(2r,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-[bis(oxiran-2-ylmethoxy)phosphorylamino]oxan-2-yl]methyl acetate</common-name>
  <description>[(2r,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-[bis(oxiran-2-ylmethoxy)phosphorylamino]oxan-2-yl]methyl acetate is a compound with the formula C20H30NO14P. With an average molecular weight of 539.40 g/mol, [(2r,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-[bis(oxiran-2-ylmethoxy)phosphorylamino]oxan-2-yl]methyl acetate is a heavy molecule.</description>
  <cas>155919-85-0</cas>
  <pubchem-id>3074280</pubchem-id>
  <chemical-formula>C20H30NO14P</chemical-formula>
  <weight>539.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T01:48:28Z</created-at>
  <updated-at type="dateTime">2026-08-30T01:48:28Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(=O)OCC1C(C(C(C(O1)NP(=O)(OCC2CO2)OCC3CO3)OC(=O)C)OC(=O)C)OC(=O)C</moldb-smiles>
  <moldb-formula>C20H30NO14P</moldb-formula>
  <moldb-inchi>InChI=1S/C20H30NO14P/c1-10(22)27-9-16-17(32-11(2)23)18(33-12(3)24)19(34-13(4)25)20(35-16)21-36(26,30-7-14-5-28-14)31-8-15-6-29-15/h14-20H,5-9H2,1-4H3,(H,21,26)/t14?,15?,16-,17-,18+,19-,20-,36?/m1/s1</moldb-inchi>
  <moldb-inchikey>KUVRPNNNWCCTBU-HHEFSXOMSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">539.1403916</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>-1.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM320431</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>[(2r,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-[bis(oxiran-2-ylmethoxy)phosphorylamino]oxan-2-yl]methyl acetate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic acids and derivatives</superklass>
  <klass>Carboxylic acids and derivatives</klass>
  <subklass>Tetracarboxylic acids and derivatives</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0275193</sync-id>
  <structure-inchikey>KUVRPNNNWCCTBU-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>800000000200000800000000000000010000000000080000000000000000000000000000000000000000000000000000800000000000000000002000000004000040000080000000000200020000020800000000100000000000000000000200000210000000002000000000000000000020000000800000000000000500010000040000000000000000200800080000040100040000000020000000020000000000000000000000000000100000000000000000000000004000000100000000000000000000000000000000000000000000000080000000000000004000000000000000000000000000000000450000002800000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJgAAAIABBgBgAAAAAQMGACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:28:40Z</structure-indexed-at>
</compound>
